Advanced Eye Care Technology

OCT gives our doctors highly detailed, cross-sectional images of the retina, macula, and optic nerve, similar to being able to view the individual layers of these structures rather than simply looking at their surface.

OCT can help identify and monitor conditions including glaucoma, macular degeneration, diabetic eye disease, macular swelling, and other retinal and optic nerve disorders. Because OCT measurements can be compared over time, even subtle changes may be detected and monitored before significant vision loss occurs.

OCT-A takes retinal imaging a step further by providing detailed images of the tiny blood vessels within the retina and surrounding tissues without the need for injected dye.

By evaluating blood flow and changes within the retinal circulation, OCT-A can help our doctors identify abnormal or reduced blood flow associated with conditions such as diabetic retinopathy, macular degeneration, retinal vascular disease, and other disorders affecting the eye’s circulation.

Because the health of retinal blood vessels can sometimes reflect broader vascular health, these images may also provide clues that warrant additional medical evaluation.

Traditional retinal examination provides an important view of the back of the eye. Ultra-widefield imaging allows us to capture a much broader view of the retina, including areas far into the peripheral retina that can otherwise be difficult to document.

This technology can help identify changes associated with diabetic retinopathy, retinal tears or detachments, vascular abnormalities, inflammation, and other retinal conditions.

The images also create a valuable baseline that allows our doctors to compare your retina from one visit to the next and recognize changes that may otherwise be difficult to detect.

Ultrasound allows our doctors to evaluate the eye using sound waves, providing important information when structures cannot be adequately seen through traditional examination or imaging.

A-scan ultrasonography provides precise measurements of the eye and can help evaluate the size and position of ocular structures.

B-scan ultrasonography creates a two-dimensional image of structures inside and behind the eye. It can be especially valuable when the view of the retina is limited by conditions such as a dense cataract, bleeding inside the eye, or other media opacity.

B-scan imaging can assist in evaluating conditions such as retinal detachment, vitreous abnormalities, masses, and other structural changes within the eye.

Every cornea has its own unique shape. Corneal topography creates a detailed map of the curvature and contour of the front surface of your eye.

This information can help our doctors detect conditions such as keratoconus and irregular astigmatism, evaluate changes in corneal shape, and provide more precise care for patients who need specialty contact lenses.

Detailed corneal measurements can also help us better understand why a patient may experience blurred or distorted vision even when a traditional prescription does not tell the whole story.

Your vision includes much more than what you see directly in front of you. Visual field testing measures your central and peripheral vision and can identify areas where sensitivity has been reduced.

Visual field testing is particularly important in the diagnosis and monitoring of glaucoma and optic nerve disease. Certain patterns of visual field loss may also suggest neurological conditions that require additional evaluation.

By repeating testing over time, our doctors can determine whether vision remains stable or whether a condition is progressing.

Dry eye disease is often more complex than simply not producing enough tears. In many patients, the problem involves the quality of the tear film or the function of the oil-producing glands within the eyelids.

Our technology allows us to evaluate the underlying cause of your symptoms and develop a treatment plan designed specifically for your eyes.

Meibography provides detailed images of the meibomian glands, the tiny glands within the eyelids responsible for producing the oils that prevent tears from evaporating too quickly.

This painless, non-invasive technology allows our doctors to evaluate gland structure and identify signs of meibomian gland dysfunction (MGD), one of the most common contributors to dry eye disease.

Identifying gland changes early can help us recommend treatment designed to preserve gland function, improve the stability of the tear film, and relieve symptoms such as burning, irritation, redness, and fluctuating vision.

OptiLift® is a non-invasive treatment designed to stimulate the muscles and tissues surrounding the eyes and eyelids.

For appropriately selected patients, improving eyelid function may support healthier blinking and more effective distribution of the tear film across the surface of the eye. OptiLift may be incorporated into an individualized treatment plan for patients experiencing symptoms related to dry eye or meibomian gland dysfunction.

OptiLight® uses precisely controlled intense pulsed light technology as part of the treatment of dry eye disease associated with meibomian gland dysfunction.

Treatment targets inflammation around the eyelids and can help improve meibomian gland function and tear-film stability. For appropriate patients, a series of treatments may help reduce symptoms such as burning, redness, irritation, dryness, and fluctuating vision.